3DBio Therapeutics

3DBio Therapeutics operates as a biotechnology company. The Company develops living tissue implants with structural and functional integrity with a four-part technology platform including novel and proprietary 3D-bioprinter, bio-ink specialized cell culture system, and implantable protective shell. 3DBio Therapeutics serves patients in the United States.